Trial · NCT04465968
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
NCT04465968, Phase 3, Not yet recruiting, National Cancer Center Hospital East
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy and Safety of CRT, Durvalumab and Surgery for SST. Trials, record NCT04465968. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04465968
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy and Safety of CRT, Durvalumab and Surgery for SST
- NCT number
- NCT04465968
- Status
- Not yet recruiting
- Phases
- Phase 3
- Enrollment
- 84 participants, estimated
- Lead sponsor
- National Cancer Center Hospital East
- Conditions
- Superior Sulcus Tumor, Non-small Cell Lung Cancer Stage IIB, Non Small Cell Lung Cancer Stage III
- Interventions
- Cisplatin, S1, concurrent radiotherapy, Durvalumab, Surgery, Durvalumab
- First posted
- 2020-07-10
- Last updated
- 2020-07-10
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 3-year overall survival rate (3y-OS) | 3 years | 3-year overall survival rate |
| Secondary | 3-year progression-free survival rate (3y-PFS) | 3 years | 3-year progression-free survival rate |
| Secondary | 5-year progression-free survival rate (5y-PFS) | 5 years | 5-year progression-free survival rate |
| Secondary | 5-year overall survival rate (5y-OS) | 5 years | 5-year overall survival rate |
| Secondary | Mode of recurrence | 5 years | Mode of recurrence in surgical cases |
| Secondary | Local recurrence rate | 5 years | Proportion of local failure in surgical cases |
| Secondary | Objective response rate (ORR) | 1 year 6 months | Objective response rate according to RECIST and iRECIST |
| Secondary | Resection rate | 1 year 6 months | Proportion of surgical cases |
| Secondary | Pathological complete resection rate (R0 rate) | 1 year 6 months | Proportion of pathologcal complete resection in surgical cases |
| Secondary | Pathological complete response rate (pCR rate) | 1 year 6 months | Proportion of pathologcal complete response in surgical cases |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04465968
GET https://conductscience.org/api/trials/v1/NCT04465968/registered